ERBB2 and gastric cancer: In vitro, human gastric cancer cells (N87) labeled by HER2-IONPs displayed negative contrast enhancement in T2-weighted MR images, in which the signal significantly decreased by 44.6 ± 7.8% than that in the control cells.